Point72 Asset Management
SYRE icon

Point72 Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Point72 Asset Management’s Portfolio SYRE Stock Details SYRE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
2025
Q4 		$21.7M Buy
2021
Q3 		– Sell
2021
Q2 		$3.27M Sell
2021
Q1 		$11.9M Sell
2020
Q4 		$23M Buy
2018
Q4 		– Sell
2018
Q3 		$2.54M Buy